Hong Kong Stock Market Anomaly | Keji Pharmaceutical-B (02171.HK) Fell by More Than 4%, Expected Net Loss in the First Half of the Year Not Exceeding 80 Million RMB, Significantly Narrower Than the Same Period Last Year.
According to the Wisdom Financial APP, Sci Pharmtech-B (02171.HK) fell more than 4%, as of the time of this report, down 4.86% to 23.5 Hong Kong dollars, with a turnover of 36.08 million Hong Kong dollars.
Latest
